NDC 0078-0736

ALOMIDE

Lodoxamide Tromethamine

ALOMIDE is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Lodoxamide Tromethamine.

• Product ID: 0078-0736_74317375-53a5-44f7-91ea-aa5f5cfe1851
• NDC: 0078-0736
• Product Type: Human Prescription Drug
• Proprietary Name: ALOMIDE
• Generic Name: Lodoxamide Tromethamine
• Dosage Form: Solution/ Drops
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 1993-09-30
• Marketing Category: NDA /
• Application Number: NDA020191
• Labeler Name: Novartis Pharmaceuticals Corporation
• Substance Name: LODOXAMIDE TROMETHAMINE
• Active Ingredient Strength: 1 mg/mL
• Pharm Classes: Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0078-0736-10

1 BOTTLE in 1 CARTON (0078-0736-10) > 10 mL in 1 BOTTLE

• Marketing Start Date: 2022-08-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "ALOMIDE" or generic name "Lodoxamide Tromethamine"

NDC	Brand Name	Generic Name
0065-0345	ALOMIDE	lodoxamide tromethamine
0078-0736	ALOMIDE	lodoxamide tromethamine